The Clinical Utility of Plasma Epstein–Barr Virus DNA Assays in Nasopharyngeal Carcinoma: The Dawn of a New Era?: A Systematic Review and Meta-Analysis of 7836 Cases

The Clinical Utility of Plasma Epstein–Barr Virus DNA Assays in Nasopharyngeal Carcinoma: The Dawn of a New Era?: A Systematic Review and Meta-Analysis of 7836 Cases

In this study, we assessed the potential of plasma Epstein–Barr virus (EBV) DNA assays to predict clinical outcomes in a large sample of nasopharyngeal carcinoma (NPC) patients and proposed a risk stratification model based on standardized EBV DNA load monitoring.

Bibliographic Details
Main Authors: Zhang, Wenna, Chen, Yupei, Chen, Lei, Guo, Rui, Zhou, Guanqun, Tang, Linglong, Mao, Yanping, Li, Wenfei, Liu, Xu, Du, Xiaojing, Sun, Ying, Ma, Jun
Format: Online
Language:English
Published: Wolters Kluwer Health 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602858/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602858/

Similar Items